Michael Marentette

479 total citations
11 papers, 403 citations indexed

About

Michael Marentette is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Pharmacology. According to data from OpenAlex, Michael Marentette has authored 11 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 4 papers in Cardiology and Cardiovascular Medicine and 3 papers in Pharmacology. Recurrent topics in Michael Marentette's work include Inflammatory mediators and NSAID effects (3 papers), Pharmaceutical Practices and Patient Outcomes (3 papers) and Lipoproteins and Cardiovascular Health (3 papers). Michael Marentette is often cited by papers focused on Inflammatory mediators and NSAID effects (3 papers), Pharmaceutical Practices and Patient Outcomes (3 papers) and Lipoproteins and Cardiovascular Health (3 papers). Michael Marentette collaborates with scholars based in Canada and United States. Michael Marentette's co-authors include William C. Gerth, Kelly B. Zarnke, Chantal Bourgault, Martin Sénécal, Sheldon X. Kong, Marc Brisson, Jean‐Pierre Grégoire, Jacques LeLorier, Elham Rahme and Cheryl Attard and has published in prestigious journals such as The American Journal of Gastroenterology, PharmacoEconomics and Current Medical Research and Opinion.

In The Last Decade

Michael Marentette

11 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Marentette Canada 9 216 132 123 97 90 11 403
Ezio Degli Esposti Italy 12 417 1.9× 232 1.8× 170 1.4× 145 1.5× 27 0.3× 47 688
Wilson Y.S. Leung Hong Kong 8 75 0.3× 101 0.8× 63 0.5× 126 1.3× 63 0.7× 10 505
A. Fletcher United States 7 422 2.0× 86 0.7× 72 0.6× 91 0.9× 35 0.4× 10 534
Karolina Obońska Poland 15 319 1.5× 144 1.1× 48 0.4× 59 0.6× 26 0.3× 36 578
Elizabeth Marrett United States 14 133 0.6× 138 1.0× 162 1.3× 100 1.0× 23 0.3× 29 642
Ammar Jesri United States 5 400 1.9× 46 0.3× 100 0.8× 49 0.5× 23 0.3× 5 674
Jochen Schuler Austria 9 271 1.3× 62 0.5× 146 1.2× 279 2.9× 10 0.1× 10 691
W Vetter Switzerland 10 159 0.7× 62 0.5× 23 0.2× 37 0.4× 43 0.5× 25 377
Niteesh K. Choudhry United States 8 216 1.0× 131 1.0× 217 1.8× 59 0.6× 8 0.1× 9 511
Katrin Farker Germany 10 43 0.2× 28 0.2× 45 0.4× 134 1.4× 104 1.2× 31 483

Countries citing papers authored by Michael Marentette

Since Specialization
Citations

This map shows the geographic impact of Michael Marentette's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Marentette with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Marentette more than expected).

Fields of papers citing papers by Michael Marentette

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Marentette. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Marentette. The network helps show where Michael Marentette may publish in the future.

Co-authorship network of co-authors of Michael Marentette

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Marentette. A scholar is included among the top collaborators of Michael Marentette based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Marentette. Michael Marentette is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Fan, Tao, et al.. (2021). S390 Estimating the Indirect and Intangible Costs Associated With Eosinophilic Esophagitis. The American Journal of Gastroenterology. 116(1). S171–S172. 2 indexed citations
2.
Sénécal, Martin, George Fodor, Claude Gagné, et al.. (2008). Limitations of statin monotherapy for the treatment of dyslipidemia: a projection based on the Canadian lipid study – observational. Current Medical Research and Opinion. 25(1). 47–55. 7 indexed citations
3.
Kohli, Michele, Cheryl Attard, Annette Lam, et al.. (2006). Cost Effectiveness of Adding Ezetimibe to Atorvastatin Therapy in Patients Not at Cholesterol Treatment Goal in Canada. PharmacoEconomics. 24(8). 815–830. 18 indexed citations
4.
Bourgault, Chantal, Martin Sénécal, Marc Brisson, Michael Marentette, & Jean‐Pierre Grégoire. (2005). Persistence and discontinuation patterns of antihypertensive therapy among newly treated patients: a population-based study. Journal of Human Hypertension. 19(8). 607–613. 96 indexed citations
5.
Bourgault, Chantal, Jean Davignon, George Fodor, et al.. (2005). Statin therapy in Canadian patients with hypercholesterolemia: the Canadian Lipid Study -- Observational (CALIPSO).. PubMed. 21(13). 1187–93. 36 indexed citations
6.
Sebaldt, Rolf J., Annie Petrie, Charles H. Goldsmith, & Michael Marentette. (2004). Appropriateness of NSAID and Coxib prescribing for patients with osteoarthritis by primary care physicians in Ontario: results from the CANOAR study.. PubMed. 10(11 Pt 1). 742–50. 19 indexed citations
7.
Burgess, Ellen, George W. Carides, William C. Gerth, Michael Marentette, & Isabelle Chabot. (2004). Losartan reduces the costs associated with nephropathy and end-stage renal disease from type 2 diabetes: Economic evaluation of the RENAAL study from a Canadian perspective.. PubMed. 20(6). 613–8. 15 indexed citations
8.
Lambert, Jean, et al.. (2002). Impact of migraine symptoms on health care use and work loss in Canada in patients randomly assigned in a phase III clinical trial.. PubMed. 9(3). 158–64. 15 indexed citations
9.
Rahme, Elham, Michael Marentette, Sheldon X. Kong, & Jacques LeLorier. (2002). Use of NSAIDs, COX‐2 inhibitors, and acetaminophen and associated coprescriptions of gastroprotective agents in an elderly population. Arthritis Care & Research. 47(6). 595–602. 52 indexed citations
10.
Marentette, Michael, et al.. (2002). Antihypertensive persistence and drug class.. PubMed. 18(6). 649–56. 104 indexed citations
11.
Marshall, John K., James M. Pellissier, Cheryl Attard, Sheldon X. Kong, & Michael Marentette. (2001). Incremental Cost-Effectiveness Analysis Comparing Rofecoxib with Nonselective NSAIDs in Osteoarthritis. PharmacoEconomics. 19(10). 1039–1049. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ezio Degli Esposti Breakdown of academic impact, for papers by Wilson Y.S. Leung Breakdown of academic impact, for papers by A. Fletcher Breakdown of academic impact, for papers by Karolina Obońska Breakdown of academic impact, for papers by Elizabeth Marrett Breakdown of academic impact, for papers by Ammar Jesri Breakdown of academic impact, for papers by Jochen Schuler Breakdown of academic impact, for papers by W Vetter Breakdown of academic impact, for papers by Niteesh K. Choudhry Breakdown of academic impact, for papers by Katrin Farker
Rankless by CCL
2026